127 results on '"Morrow, David A."'
Search Results
2. Current practices in the management of temporary mechanical circulatory support: A survey of CICU directors in North America
3. Continuum of Preshock to Classic Cardiogenic Shock in the Critical Care Cardiology Trials Network Registry
4. Characteristics and Outcomes of Adults With Congenital Heart Disease in the Cardiac Intensive Care Unit
5. Early Serial Assessment of Aggregate Vasoactive Support and Mortality in Cardiogenic Shock: Insights From the Critical Care Cardiology Trials Network Registry
6. Effects of Sacubitril/Valsartan vs Valsartan in De Novo vs Acute on Chronic HFpEF and HFmrEF
7. Variation in risk-adjusted cardiac intensive care unit (CICU) length of stay and the association with in-hospital mortality: An analysis from the Critical Care Cardiology Trials Network (CCCTN) registry
8. Prognostic performance of the IABP-SHOCK II Risk Score among cardiogenic shock subtypes in the critical care cardiology trials network registry
9. Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart Failure
10. Training Paradigms in Critical Care Cardiology: A Scoping Review of Current Literature
11. Does China's pathway to carbon neutrality require the integration of land-based biological negative emission solutions with geochemical and chemical alternatives?
12. Efficacy and Safety of Non–Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation
13. Association of Sacubitril/Valsartan vs Valsartan With Blood Pressure Changes and Symptomatic Hypotension: the PARAGLIDE-HF Trial
14. CD8 + T cell targeting of tumor antigens presented by HLA-E
15. Unveiling new horizons: revolutionary insights into acute myocarditis and optimal mechanical circulatory support timing
16. Risk of new‐onset diabetes and efficacy of pharmacological weight loss therapy.
17. Viral escape mutations do not account for non-protection from SIVmac239 challenge in RhCMV/SIV vaccinated rhesus macaques.
18. Sex Differences in Characteristics, Resource Utilization, and Outcomes of Cardiogenic Shock: Data From the Critical Care Cardiology Trials Network (CCCTN) Registry.
19. Targeted proteomic profiling of cardiogenic shock in the cardiac intensive care unit.
20. Acute cardiac and intensive care chronicles: navigating the intersection of cardiovascular health, recreational drug use, and beyond!
21. Pulmonary Artery Diastolic Pressure as a Surrogate for Pulmonary Capillary Wedge Pressure in Cardiogenic Shock
22. March 2024 issue of the European Heart Journal Acute Cardiovascular Care
23. Modes of Death in Patients with Cardiogenic Shock in the Cardiac Intensive Care Unit: A Report from the Critical Care Cardiology Trials Network
24. Epidemiology of cardiogenic shock using the Shock Academic Research Consortium (SHARC) consensus definitions
25. American Heart Association Cardiogenic Shock Registry: Design and Implementation.
26. Acute cardiovascular and intensive care chronicles: ‘inception revealed—navigating the veno-arterial extracorporeal membrane oxygenation terrain and beyond’
27. Interhospital Variation in Admissions Managed With Critical Care Therapies or Invasive Hemodynamic Monitoring in Tertiary Cardiac Intensive Care Units: An Analysis From the Critical Care Cardiology Trials Network Registry
28. As we reflect on the year 2023…….
29. AβYSS trial in perspective: beta-blockers following myocardial infarction among patients with preserved ejection fraction.
30. Transcriptomic Profiling at the Maternal-to-Zygotic Transition in Leech, Helobdella austinensis.
31. Prioritizing Non-Carbon Dioxide Removal Mitigation Strategies Could Reduce the Negative Impacts Associated with Large-Scale Reliance on Negative Emissions.
32. Natriuretic peptides, body mass index and heart failure risk: Pooled analyses of SAVOR‐TIMI 53, DECLARE‐TIMI 58 and CAMELLIA‐TIMI 61.
33. Biomarkers in the IL-6 Pathway and Cardiovascular Outcomes in Patients With STEMI in LATITUDE-TIMI 60
34. Complications in patients with cardiogenic shock on veno-arterial extracorporeal membrane oxygenation therapy: distribution and relevance. Results from an international, multicentre cohort study
35. Efficacy and safety of mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: DanGer trial in perspective.
36. Revolutionizing cardiac care: insights into shock prognosis, myocardial infarction management, and platelet inhibition.
37. Resilience and renewal: charting the future of cardiovascular care in a changing world
38. EFFECTS OF SACUBITRIL/VALSARTAN OR VALSARTAN IN DE NOVO VS. CHRONIC HFPEF AND HFMREF: THE PARAGLIDE-HF TRIAL
39. CARDIOGENIC SHOCK EPIDEMIOLOGY IN CARDIAC INTENSIVE CARE UNITS (CICUS) USING THE FRAMEWORK OF THE SHOCK ACADEMIC RESEARCH CONSORTIUM (SHARC) CONSENSUS DEFINITIONS
40. USE OF PALLIATIVE CARE SERVICES IN PATIENTS WITH CARDIOGENIC SHOCK: INSIGHTS FROM THE CRITICAL CARE CARDIOLOGY TRIALS NETWORK (CCCTN) REGISTRY
41. EARLY CHANGES IN AGGREGATE VASOACTIVE SUPPORT AND MORTALITY IN CARDIOGENIC SHOCK: INSIGHTS FROM THE CRITICAL CARE CARDIOLOGY TRIALS NETWORK REGISTRY
42. CONCURRENT EVALUATION OF HSTNI AND HSTNT AND THEIR ASSOCIATIONS WITH CARDIOVASCULAR EVENTS IN 37,886 PATIENTS WITH STABLE ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
43. SOLUBLE SUPPRESSION OF TUMORIGENICITY 2 (SST2) AND CARDIOVASCULAR OUTCOMES IN PERSONS WITH TYPE 2 DIABETES MELLITUS RANDOMIZED TO DAPAGLIFLOZIN OR PLACEBO: ANALYSES FROM THE DECLARE-TIMI 58 TRIAL
44. IN-HOSPITAL OR OUT-OF-HOSPITAL INITIATION OF SACUBITRIL/VALSARTAN VERSUS VALSARTAN IN PATIENTS WITH MILDLY REDUCED OR PRESERVED EJECTION FRACTION AFTER A WORSENING HEART FAILURE EVENT: THE PARAGLIDE-HF TRIAL
45. Editor's chronicles: redefining pathways in acute cardiac care.
46. Efficacy And Safety Of Sacubitril/valsartan In Patients Hospitalized With Heart Failure: A Prespecified, Pooled Individual Patient-level Analysis Of PIONEER-HF And PARAGLIDE-HF
47. Embracing the Olympic spirit: pioneering cardiac care insights from the 2024 European Society of Cardiology scientific meeting and more!
48. Resource use among patients with transcatheter cardiac valve procedures admitted to contemporary cardiac intensive care units: insights from CCCTN.
49. Acute cardiovascular and intensive care chronicles: crossing new frontiers in advanced cardiovascular therapeutics.
50. Ensuring efficient development of personalized medicine by addressing regulatory needs: What role can research infrastructures play?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.